Purdue
By Dietrich Knauth NEW YORK (Reuters) -Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction crisis in the U.S., several state attorneys general said Thursday. The settlement was announced…
By Dietrich Knauth NEW YORK (Reuters) – Purdue Pharma on Tuesday asked a U.S. bankruptcy judge for a 60-day freeze on lawsuits against its owners, members of the wealthy Sackler family, in its first court appearance since a landmark Supreme Court ruling upended its bankruptcy settlement. Purdue’s attorney Marshall Huebner…
By Dietrich Knauth NEW YORK (Reuters) – Purdue Pharma’s creditors sought permission from a U.S. bankruptcy court on Monday to sue the company’s wealthy owners, arguing that the litigation can serve as both a negotiating tool and a fallback option as the OxyContin maker re-starts talks on a bankruptcy settlement.…
By Dietrich Knauth NEW YORK (Reuters) – Bankruptcy may become a less attractive way to resolve sprawling lawsuits after a U.S. Supreme Court ruling scuttled OxyContin maker Purdue Pharma’s Chapter 11 settlement and sharply scaled back a court’s ability to wipe away legal claims against entities that have not filed…
